Mostrando 1,941 - 1,960 Resultados de 3,271 Para Buscar '"gambia"', tiempo de consulta: 0.19s Limitar resultados
  1. 1941
    por Chandak, Giriraj R., Silver, Matt J., Saffari, Ayden, Lillycrop, Karen A., Shrestha, Smeeta, Sahariah, Sirazul Ameen, Di Gravio, Chiara, Goldberg, Gail, Tomar, Ashutosh Singh, Betts, Modupeh, Sajjadi, Sara, Acolatse, Lena, James, Philip, Issarapu, Prachand, Kumaran, Kalyanaraman, Potdar, Ramesh D., Prentice, Andrew M., Fall, Caroline H. D., Acolatse, Lena, Ahmed, Meraj, Betts, Modupeh, Chandak, Giriraj R., Chopra, Harsha, Cooper, Cyrus, Darboe, Momodou K., Di Gravio, Chiara, Fall, Caroline H. D., Gandhi, Meera, Goldberg, Gail R., Issarapu, Prachand, James, Philip, Janha, Ramatoulie, Jarjou, Landing M. A., Kaur, Lovejeet, Kehoe, Sarah H., Kumaran, Kalyanaraman, Lillycrop, Karen A., Ngum, Mohammed, Nongmaithem, Suraj S., Owens, Stephen, Potdar, Ramesh D., Prentice, Andrew M., Prentice, Ann, Priyanka, Tallapragada Divya Sri, Saffari, Ayden, Sahariah, Sirazul Ameen, Sajjadi, Sara, Sane, Harshad, Shrestha, Smeeta, Silver, Matt J., Tomar, Ashutosh Singh, Ward, Kate A., Yadav, Dilip Kumar, Yajnik, Chittaranjan S.
    Publicado 2017
    “…METHODS: The original trials were the Mumbai Maternal Nutrition Project (MMNP, ISRCTN62811278) in which Indian women were offered a daily snack made from micronutrient-rich foods or low-micronutrient foods (controls), and the Peri-conceptional Multiple Micronutrient Supplementation Trial (PMMST, ISRCTN13687662) in rural Gambia, in which women were offered a daily multiple micronutrient (UNIMMAP) tablet or placebo. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  2. 1942
    “…Prognostic performance of both signatures was validated in an independent cohort of 1,948 HIV-negative household TB contacts from The Gambia (aged 15–60 years, 66% female), longitudinally followed up for 2 years between March 5, 2007 and October 21, 2010, sampled at baseline, month 6, and month 18. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  3. 1943
    “…Overall, the pooled prevalence estimate of Plasmodium spp. and HBV co-infection was 6% (95% CI 4–7%, Cochran's Q statistic < 0.001, I(2): 95.8%), with prevalences of 10% in Gambia (95% CI: 8–12%, weight: 4.95%), 8% in Italy (95% CI 5–12%, weight: 3.8%), 7% in Nigeria (95% CI 4–10%, weight: 53.5%), and 4% in Brazil (95% CI 2–5%, weight: 19.9%). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  4. 1944
    “…FINDINGS: 9·6% (95% CI 5·2–16·9) of adults aged 60 years or older across sub-Saharan Africa had an estimated travel time to the nearest hospital of 6 h or longer, varying from 0·0% (0·0–3·7) in Burundi and The Gambia to 40·9% (31·8–50·7) in Sudan. For the nearest health-care facility of any type (whether primary, secondary, or tertiary care), 15·9% (95% CI 10·1–24·4) of adults aged 60 years or older across sub-Saharan Africa had an estimated travel time of 2 h or longer, ranging from 0·4% (0·0–4·4) in Burundi to 59·4% (50·1–69·0) in Sudan. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  5. 1945
    “…METHODS: We whole-genome sequenced 3233 invasive pneumococcal disease isolates from laboratory-based surveillance programmes in Hong Kong (n=78), Israel (n=701), Malawi (n=226), South Africa (n=1351), The Gambia (n=203), and the USA (n=674). The genomes represented pneumococci from before and after pneumococcal conjugate vaccine (PCV) introductions and were from children younger than 3 years. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  6. 1946
    “…In some countries monitoring programs have only been explored by research teams mostly at the catchment or local level (e.g., Brazil, Mexico, Chile, China, India, Malaysia, Thailand, Vietnam) or implemented by citizen science groups (e.g., Southern Africa, Gambia, East Africa, Australia, Brazil, Canada). The existing large-extent assessments show a striking loss of biodiversity in the last 2–3 decades in Japanese and New Zealand rivers (e.g., 42% and 70% of fish species threatened or endangered, respectively). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  7. 1947
    “…METHODS: We measured 25-hydroxyvitamin D (25(OH)D) and typed the single nucleotide polymorphisms, rs4588 and rs7041, in the GC gene encoding the vitamin D binding protein (DBP) in 4509 children aged 0–8 years living in Kenya, Uganda, Burkina Faso, The Gambia and South Africa. We evaluated associations between vitamin D status and country, age, sex, season, anthropometric indices, inflammation, malaria and DBP haplotypes in regression analyses. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  8. 1948
  9. 1949
    “…The relevance and feasibility of trials of reduced dose schedules is greatest in middle- and low-income countries, such as The Gambia, where the introduction of PCV resulted in good disease control but where transmission of vaccine-type pneumococci persists. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  10. 1950
    Publicado 2019
    “…METHODS: We did a multi-site, international case-control study in nine study sites in seven countries: Bangladesh, The Gambia, Kenya, Mali, South Africa, Thailand, and Zambia. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  11. 1951
  12. 1952
    “…The trials were carried out between 2006 and 2015 in sub‐Saharan Africa (Benin, Mali, Mozambique, Tanzania, Kenya, Democratic Republic of the Congo, Burkina Faso, and The Gambia). In all three trials, the paediatric and control ACT achieved polymerase chain reaction (PCR)‐adjusted treatment failure rates of < 10% on day 28 in the per‐protocol (PP) population. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  13. 1953
    “…These trials were conducted between 1957 and 2008, in Nigeria (three trials), The Gambia (three trials), Kenya (three trials), Mozambique (two trials), Uganda (two trials), Cameroon (one trial), Burkina Faso (one trial), and Thailand (two trials). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  14. 1954
  15. 1955
  16. 1956
    “…BACKGROUND: Host-seeking of the African malaria mosquito, Anopheles gambiae sensu stricto, is guided by human odours. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
  17. 1957
    “…Members of the Anopheles gambiae complex and Anopheles funestus group are significant vectors of the malaria parasite Plasmodium species in the Afro-tropical region of the world. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  18. 1958
    “…RESULTS: The two CS formulations of pirimiphos methyl gave prolonged control of An. gambiae and Cx. quinquefasciatus. In cement huts application rates of 0.5 g/m(2) induced high mortality of An. gambiae for almost a year: overall mortality rates 87% (95% CI 82–91%) and 92% (95% CI 88–94%). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  19. 1959
    “…PCR result (n = 581) revealed that 98.9% An. arabiensis and 1.1% An. gambiae s.s. constituted An. gambiae s.l. in Ahero while this was 87% An. gambiae s.s. and 13% An. arabiensis in Iguhu. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  20. 1960
    “…An. gambiae s.s hereafter (An. gambiae) accounted for 91% (95% CI: 89–93) and An. arabiensis 8% (95% CI: 6–9) in Bungoma, while in Kisian, An. arabiensis composition was 60% (95% CI: 55–66) and An. gambiae 39% (95% CI: 34–44). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
Herramientas de búsqueda: RSS